Beijing Tiantan (China) Today
| 600161 Stock | 21.49 0.15 0.70% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Beijing Tiantan is trading at 21.49 as of the 1st of December 2024, a 0.70 percent increase since the beginning of the trading day. The stock's open price was 21.34. Beijing Tiantan has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Beijing Tiantan Biological are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of November 2024 and ending today, the 1st of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 18th of May 1998 | Category Healthcare | Classification Health Care |
Beijing Tiantan is entity of China. It is traded as Stock on SHG exchange. The company has 1.98 B outstanding shares. More on Beijing Tiantan Biological
Moving against Beijing Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Beijing Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Beijing Tiantan's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Beijing Tiantan or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Beijing Tiantan's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Beijing Tiantan's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsBeijing Tiantan can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Beijing Tiantan's financial leverage. It provides some insight into what part of Beijing Tiantan's total assets is financed by creditors.
| |||||
Beijing Tiantan Biological (600161) is traded on Shanghai Stock Exchange in China and employs 4,858 people. Beijing Tiantan is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 42.49 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Beijing Tiantan's market, we take the total number of its shares issued and multiply it by Beijing Tiantan's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Beijing Tiantan Biol operates under Biotechnology sector and is part of Health Care industry. The entity has 1.98 B outstanding shares.
Beijing Tiantan generates positive cash flow from operations, but has no cash available
Check Beijing Tiantan Probability Of Bankruptcy
Ownership AllocationBeijing Tiantan holds a total of 1.98 Billion outstanding shares. Beijing Tiantan Biological retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Beijing Ownership Details
Beijing Tiantan Biol Risk Profiles
Although Beijing Tiantan's alpha and beta are two of the key measurements used to evaluate Beijing Tiantan's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.33 | |||
| Standard Deviation | 1.98 | |||
| Variance | 3.91 | |||
| Risk Adjusted Performance | (0.05) |
Beijing Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Beijing Tiantan without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Beijing Tiantan Corporate Directors
Other Information on Investing in Beijing Stock
Beijing Tiantan financial ratios help investors to determine whether Beijing Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Beijing with respect to the benefits of owning Beijing Tiantan security.